Question

In: Statistics and Probability

A clinical trial is conducted to compare an experimental medication to placebo to reduce the symptoms...

A clinical trial is conducted to compare an experimental medication to placebo to reduce the symptoms of asthma. Two hundred participants are enrolled in the study and randomized to receive either the experimental medication or placebo. The primary outcome is self-reported reduction of symptoms. Among 100 participants who receive the experimental medication, 38 report a reduction of symptoms as compared to 21 participants of 100 assigned to placebo. When you test if there is a significant difference in the proportions of participants reporting a reduction of symptoms between the experimental and placebo groups. Use α = 0.05. What should the researcher’s conclusion be for a 5% significance level? Reject H0 because 2.64 ≥ 1.960. We have statistically significant evidence at α = 0.05 to show that there is a difference in the proportions of patients reporting a reduction in symptoms.

A) We reject H0 at the 5% level because 2.64 is greater than 1.96. We do have statistically significant evidence at α = 0.05 to show that there is a difference in the proportions of patients reporting a reduction in symptoms.

B) We fail to reject H0 at the 5% because -2.64 is less than 1.645. We do not have statistically significant evidence to show that there is a difference in the proportions of patients reporting a reduction in symptoms.

C) We fail to reject H0 at the 5% because -2.64 is less than 1.96. We do have statistically significant evidence at α = 0.05 to show that there is a difference in the proportions of patients reporting a reduction in symptoms.

D) We fail to reject H0 at the 5% because 2.64 is greater than -1.645. We do have statistically significant evidence at α = 0.05 to show that there is a difference in the proportions of patients reporting a reduction in symptoms.

Solutions

Expert Solution

Given :-

Experimental --

n1 = 100

X1= 38

P1^ = (x1/n1)

Placebo --

n2 =100

x2 = 21

P2^ = (x2/n2)

P^ = (x1+x2)/(n1+n2)

Using ti-83 calculator.

Test statistic :

Z = 2.64

And critical value = 1.960

Rejection region for two tailed test is

R ={ z , |z| >= 1.960}

Test statistic value is not in rejection region. i.e. 2.74>= 1.96

then reject H0.

#Answer :-

A) We reject H0 at the 5% level because 2.64 is greater than 1.96. We do have statistically significant evidence at alpha= 0.05 to show that there is a difference in the proportions of patients reporting a reduction in symptoms.


Related Solutions

A clinical trial is conducted to compare an experimental medication to placebo to reduce the symptoms...
A clinical trial is conducted to compare an experimental medication to placebo to reduce the symptoms of asthma. Two hundred participants are enrolled in the study and randomized to receive either the experimental medication or placebo. The primary outcome is self-reported reduction of symptoms. Among 100 participants who receive the experimental medication, 38 report a reduction of symptoms as compared to 21 participants of 100 assigned to placebo. When you test if there is a significant difference in the proportions...
A clinical trial is conducted to compare an experimental medication to placebo to reduce the symptoms...
A clinical trial is conducted to compare an experimental medication to placebo to reduce the symptoms of asthma. Two hundred participants are enrolled in the study and randomized to receive either the experimental medication or placebo. The primary outcome is self-reported reduction of symptoms. The data are recorded as follows. Change in Symptoms Treatment Much Worse Worse No change Better Much Better Experimental 11 18 36 29 11 Placebo 13 23 40 11 8 Is there a difference in change...
1. A clinical trial is conducted to compare an experimental medication to placebo to reduce the...
1. A clinical trial is conducted to compare an experimental medication to placebo to reduce the symptoms of asthma. Two hundred participants are enrolled in the study and randomized to receive either the experimental medication or placebo. The primary outcome is self-reported reduction of symptoms. Among 100 participants who receive the experimental medication, 38 report a reduction of symptoms as compared to 21 participants of 100 assigned to placebo. Is there a significant difference in the proportions of participants reporting...
A clinical trial was conducted to test whether medication A could effectively be used to reduce...
A clinical trial was conducted to test whether medication A could effectively be used to reduce the risk of a special disease among people with high risk. The results at the end of the study are listed on the table below with disease without disease total medication A 99 3377 3476 placebo 174 3098 3272 Keep 4 decimal points for your calculations in Q1 - 4, 6 - 8. 1. P(disease| medication A) = Blank 1. Fill in the blank,...
A clinical trial is planned to compare an experimental medication designed to lower blood pressure to...
A clinical trial is planned to compare an experimental medication designed to lower blood pressure to a placebo. Before starting the trial, a pilot study is conducted involving 7 participants. The objective of the study is to assess how systolic blood pressure changes over time untreated. Systolic blood pressures are measured at baseline and again 4 weeks later. Is there a statistically significant difference in blood pressures over time? Run the test at a 5% level of significance. Baseline           120     ...
A clinical trial is planned to compare an experimental medication designed to lower blood pressure to...
A clinical trial is planned to compare an experimental medication designed to lower blood pressure to a placebo. Patients are enrolled and randomized to either the experimental medication or the placebo. The data shown below are data collected at the end of the study after 6 weeks on the assigned treatment. Experimental (n=100) Placebo (n=100) Mean (SD) Systolic Blood Pressure 120.2 (15.4) 131.4 (18.9) % Hypertensive 14% 22% % With Side Effects 6% 8% Is there a significant difference in...
A clinical trial is planned to compare an experimental medication designed to lower blood pressure to...
A clinical trial is planned to compare an experimental medication designed to lower blood pressure to a placebo. Before starting the trial, a pilot study is conducted involving eight participants. The objective of the study is to assess how systolic blood pressure changes over time untreated. Systolic blood pressures are measured at baseline and again 4 weeks later Is there a statistically significant difference in blood pressures over time? Run the test at a 5% level of significance. Give each...
A clinical trial is conducted comparing a new pain reliever for arthritis to a placebo.
  A clinical trial is conducted comparing a new pain reliever for arthritis to a placebo. Participants are randomly assigned to receive the new treatment or a placebo and the outcome is pain relief within 30 minutes. Of the 120 participants who received the new medication, 44 reported pain relief, while 21 out of the 120 participants who received the placebo reported pain relief. Is there a significant difference in the proportions of patients reporting pain relief? Run the test...
A clinical trial is conducted comparing a new pain reliever for arthritis to a placebo. Participants...
A clinical trial is conducted comparing a new pain reliever for arthritis to a placebo. Participants are randomly assigned to receive the new treatment or a placebo and the outcome is pain relief within 30 minutes. The data are shown below. Pain Relief No Pain Relief New Medication 44 76 Placebo 21 99 Is there a significant difference in the proportions of patients reporting pain relief? Run the test at a 5% level of significance. Step 1.           Set up...
A clinical trial is conducted comparing a new pain reliever for arthritis to a placebo. Participants...
A clinical trial is conducted comparing a new pain reliever for arthritis to a placebo. Participants are randomly assigned to receive the new treatment or a placebo and the outcome is pain relief within 30 minutes. The data are shown here. Pain Relief No Pain Relief New Medication 45 75 Placebo 20 100 Is there a significant difference in the proportions of patients reporting pain relief? Run the test at a 5% level of significance. H0: p1= p2(equivalent to RD...
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT